Eva Řezníčková

697 total citations
44 papers, 541 citations indexed

About

Eva Řezníčková is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eva Řezníčková has authored 44 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Eva Řezníčková's work include Cancer-related Molecular Pathways (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (6 papers). Eva Řezníčková is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (6 papers). Eva Řezníčková collaborates with scholars based in Czechia, Lithuania and Portugal. Eva Řezníčková's co-authors include Vladimı́r Kryštof, Radek Jorda, Tomáš Gucký, Jiří Voller, Miroslav Strnad, Karel Berka, Václav Bazgier, Marek Zatloukal, Haresh Ajani and Aleš Imramovský and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Eva Řezníčková

41 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Řezníčková Czechia 15 259 245 146 85 50 44 541
Tomáš Gucký Czechia 14 209 0.8× 218 0.9× 115 0.8× 65 0.8× 36 0.7× 36 512
Andrii Monastyrskyi United States 12 315 1.2× 181 0.7× 169 1.2× 86 1.0× 20 0.4× 25 614
Guoyi Yan China 14 332 1.3× 228 0.9× 125 0.9× 56 0.7× 36 0.7× 39 608
Mauro Angiolini Italy 10 387 1.5× 247 1.0× 139 1.0× 45 0.5× 44 0.9× 14 587
Asaad Nematalla United States 7 269 1.0× 240 1.0× 123 0.8× 101 1.2× 39 0.8× 13 547
Theodosia Teo Australia 15 438 1.7× 168 0.7× 241 1.7× 150 1.8× 54 1.1× 25 692
Smitha Kizhake United States 14 310 1.2× 132 0.5× 162 1.1× 71 0.8× 36 0.7× 20 490
Hui-Yi Shiao Taiwan 12 271 1.0× 304 1.2× 114 0.8× 66 0.8× 17 0.3× 13 626
Xin Zhai China 16 369 1.4× 363 1.5× 153 1.0× 122 1.4× 20 0.4× 66 695
Jörg Trappe Switzerland 14 463 1.8× 153 0.6× 180 1.2× 35 0.4× 105 2.1× 15 831

Countries citing papers authored by Eva Řezníčková

Since Specialization
Citations

This map shows the geographic impact of Eva Řezníčková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Řezníčková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Řezníčková more than expected).

Fields of papers citing papers by Eva Řezníčková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Řezníčková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Řezníčková. The network helps show where Eva Řezníčková may publish in the future.

Co-authorship network of co-authors of Eva Řezníčková

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Řezníčková. A scholar is included among the top collaborators of Eva Řezníčková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Řezníčková. Eva Řezníčková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Řezníčková, Eva, et al.. (2024). Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles. Archiv der Pharmazie. 357(10). e2400282–e2400282. 2 indexed citations
2.
Řezníčková, Eva, Lukáš Malina, Hana Kolářová, et al.. (2024). Synthesis and photo-induced anticancer activity of new 2-phenylethenyl-1H-benzo[e]indole dyes. European Journal of Medicinal Chemistry. 277. 116777–116777.
3.
Řezníčková, Eva, et al.. (2024). Anticancer dinuclear Ir(III) complex activates Nrf2 and interferes with NAD(H) in cancer cells. Journal of Inorganic Biochemistry. 262. 112704–112704. 3 indexed citations
4.
Řezníčková, Eva, Radek Jorda, Milan Dejmek, et al.. (2023). Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping. Journal of Medicinal Chemistry. 66(16). 11133–11157. 8 indexed citations
5.
Řezníčková, Eva, et al.. (2023). Design and synthesis of novel 1,2,4-triazolo[4,3-b]pyridazine derivatives with anti-cancer activity. Journal of Molecular Structure. 1291. 135938–135938. 6 indexed citations
6.
Havlı́ček, Libor, Jana Škerlová, Tomáš Pospíšil, et al.. (2023). Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7. Biomedicine & Pharmacotherapy. 161. 114492–114492. 7 indexed citations
7.
Chen, Doris, Eva Řezníčková, Heidemarie Huber, et al.. (2023). Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma. Frontiers in Oncology. 13. 1238883–1238883. 4 indexed citations
8.
Jorda, Radek, et al.. (2023). Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 41(2). 210–219. 1 indexed citations
9.
Jorda, Radek, et al.. (2022). Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors. International Journal of Molecular Sciences. 23(24). 16169–16169. 1 indexed citations
10.
Gucký, Tomáš, et al.. (2022). Synthesis and biological activity evaluation of novel 2,6,9-trisubstituted purine conjugates as potential protein kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 60. 128603–128603. 3 indexed citations
11.
Jansa, Josef, Radek Jorda, Jana Škerlová, et al.. (2021). Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure. European Journal of Medicinal Chemistry. 216. 113309–113309. 10 indexed citations
12.
Řezníčková, Eva, Lukáš Malina, Martin Kubala, et al.. (2021). Synthesis of N-aryl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-amines and their photodynamic properties in the human skin melanoma cell line G361. Bioorganic Chemistry. 119. 105570–105570. 8 indexed citations
13.
Jorda, Radek, Eva Řezníčková, Jacek W. Morzycki, et al.. (2019). Synthesis of novel galeterone derivatives and evaluation of their in vitro activity against prostate cancer cell lines. European Journal of Medicinal Chemistry. 179. 483–492. 16 indexed citations
14.
Řezníčková, Eva, Tomáš Gucký, Veronika Kováčová, et al.. (2019). Activity of 2,6,9-trisubstituted purines as potent PDGFRα kinase inhibitors with antileukaemic activity. European Journal of Medicinal Chemistry. 182. 111663–111663. 9 indexed citations
15.
Jorda, Radek, et al.. (2017). Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(2). 354–363. 13 indexed citations
16.
Jorda, Radek, Ján Dušek, Eva Řezníčková, et al.. (2017). Synthesis and antiproteasomal activity of novel O -benzyl salicylamide-based inhibitors built from leucine and phenylalanine. European Journal of Medicinal Chemistry. 135. 142–158. 6 indexed citations
17.
Řezníčková, Eva, Tomáš Gucký, Marek Zatloukal, et al.. (2015). 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic & Medicinal Chemistry Letters. 25(11). 2298–2301. 10 indexed citations
18.
Grubinger, Markus, Eva Řezníčková, Thomas S. Weiß, et al.. (2013). Novel Inhibitors of Cyclin-Dependent Kinases Combat Hepatocellular Carcinoma without Inducing Chemoresistance. Molecular Cancer Therapeutics. 12(10). 1947–1957. 27 indexed citations
19.
Imramovský, Aleš, Radek Jorda, Karel Pauk, et al.. (2013). Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines. European Journal of Medicinal Chemistry. 68. 253–259. 26 indexed citations
20.
Zatloukal, Marek, Radek Jorda, Tomáš Gucký, et al.. (2012). Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases. European Journal of Medicinal Chemistry. 61. 61–72. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomáš Gucký Breakdown of academic impact, for papers by Andrii Monastyrskyi Breakdown of academic impact, for papers by Guoyi Yan Breakdown of academic impact, for papers by Mauro Angiolini Breakdown of academic impact, for papers by Asaad Nematalla Breakdown of academic impact, for papers by Theodosia Teo Breakdown of academic impact, for papers by Smitha Kizhake Breakdown of academic impact, for papers by Hui-Yi Shiao Breakdown of academic impact, for papers by Xin Zhai Breakdown of academic impact, for papers by Jörg Trappe
Rankless by CCL
2026